NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis

Rheumatology International

Volumn 29, Issue 4, 2009, Pages 469-475

  Reis, Eliana A G ^a   Athanazio, Daniel A ^a,b   Lima, Isabella ^c   E Silva, Natália Oliveira ^d   Andrade, Jorge Clarencio S ^a   Jesus, Ronden N ^a,b   Barbosa, Lúcio M ^a   Reis, Mitermayer G ^a,b,d   Santiago, Mittermayer B ^c,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c HOSPITAL SANTA IZABEL   (Brazil)

^d ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

Author keywords

Leukocytes; Natural killer cells; Rheumatoid arthritis; Rituximab; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; IMMUNOGLOBULIN; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; RITUXIMAB; SALAZOSULFAPYRIDINE; TACROLIMUS;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CD4+ CD25+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; NATURAL KILLER CELL; NATURAL KILLER T CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NATURAL KILLER T-CELLS;

EID: 59449107122     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0719-0     Document Type: Article

References (24)

1. W Stohl RJ Looney 2006 B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks? Clin Immunol 121 1 12 10.1016/j.clim.2006.03.010
2. V Strand R Kimberly JD Isaacs 2007 Biologic therapies in rheumatology: lessons learned, future directions Nat Rev Drug Discov 6 75 92 10.1038/nrd2196
3. PP Sfikakis JN Boletis S Lionaki 2005 Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial Arthritis Rheum 52 501 513 10.1002/art.20858
4. Y Tanaka K Yamamoto T Takeuchi 2007 A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus Mod Rheumatol 17 191 197 10.1007/s10165-007-0565-z
5. A Kavanaugh S Rosengren SJ Lee 2007 Assessment of rituximab's immunomodulatory synovial effects (the ARISE trial). I: clinical and synovial biomarker results Ann Rheum Dis 67 402 428 10.1136/ard.2007.074229
6. JS Smolen EC Keystone P Emery 2007 Consensus statement on the use of rituximab in patients with rheumatoid arthritis Ann Rheum Dis 66 143 150 10.1136/ard.2006.061002
7. JL Browning 2006 B cells move to centre stage: novel opportunities for autoimmune disease treatment Nat Rev Drug Discov 5 564 576 10.1038/nrd2085
8. PP Sfikakis VL Souliotis KG Fragiadaki 2007 Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis Clin Immunol 123 66 73 10.1016/j.clim.2006.12.006
9. E Toubi A Kessel G Slobodin 2007 Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis Ann Rheum Dis 66 818 820 10.1136/ard.2006.062505
10. FD Shi F Van Kaer 2006 Reciprocal regulation between natural killer cells and autoreactive T cells Nat Rev Immunol 6 751 760 10.1038/nri1935
11. S Miyake T Yamamura 2007 NKT cells and autoimmune diseases: unraveling the complexity Curr Top Microbiol Immunol 314 251 267 10.1007/978-3-540-69511-0- 10
12. MR Green AS Kennell MJ Larche 2005 Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients Clin Exp Immunol 141 165 173 10.1111/j.1365-2249. 2005.02822.x
13. MR Green AS Kennell MJ Larche 2007 Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production Arthritis Rheum 56 303 310 10.1002/art.22326
14. Shevach EM, Piccirillo CA, Thornton AM et al. (2003) Control of T cell activation by CD4+CD25+ suppressor T cells. Novartis Found Symp 252:24-36, discussion 36-44, 106-114
15. S Barath M Aleksza T Tarr 2007 Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus Lupus 16 489 496 10.1177/0961203307080226
16. JC Crispin A Martinez J Alcocer-Varela 2003 Quantification of regulatory T cells in patients with systemic lupus erythematosus J Autoimmun 21 273 276 10.1016/S0896-8411(03)00121-5
17. MA Cooper TA Fehniger MA Caligiuri 2001 The biology of human natural killer-cell subsets Trends Immunol 22 633 640 10.1016/S1471-4906(01)02060-9
18. DM Vitelli-Avelar R Sathler-Avelar JC Dias 2005 Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes Scand J Immunol 62 297 308 10.1111/j.1365-3083.2005.01668.x
19. T Jonsdottir I Gunnarsson A Risselada 2007 Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response Ann Rheum Dis 56 1263 1272
20. R McMillan 2007 The pathogenesis of chronic immune thrombocytopenic purpura Semin Hematol 44 S3 S11 10.1053/j.seminhematol.2007.11.002
21. A Moretta C Bottino MC Mingari 2002 What is a natural killer cell? Nat Immunol 3 6 8 10.1038/ni0102-6
22. JA Bowles SY Wang BK Link 2006 Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab Blood 108 2648 2654 10.1182/blood-2006-04-020057
23. M Bonelli K von Dalwigk A Savitskaya 2008 Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus (SLE): a comparative phenotypic analysis Ann Rheum Dis 67 664 671 10.1136/ard.2007.074690
24. T Vallerskog I Gunnarsson M Widhe 2007 Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE Clin Immunol 122 62 74 10.1016/j.clim.2006.08.016